DVAX
Dynavax Technologies Corp
Price:  
15.50 
USD
Volume:  
2,008,968.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-100.0%
Upside

As of 2026-03-20, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 0.00 USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.50 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -100.0%.

The range of the Relative Valuation is (6.86) - 9.70 USD.

Range Selected
Trailing P/E multiples 18.0x - 23.7x 20.6x
Forward P/E multiples 21.2x - 27.1x 22.0x
Fair Price (6.86) - 9.70 0.00
Upside -144.2% - -37.4% -100.0%
15.50 USD
Stock Price
0.00 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2026-02-09 -40.60
2026-02-06 -40.60
2026-02-05 -40.57
2026-02-04 -40.63
2026-02-03 -40.55
2026-02-02 -40.57
2026-01-30 -40.56
2026-01-29 -40.55
2026-01-28 -40.55
2026-01-27 -40.55
2026-01-26 -40.65
2026-01-23 -40.63
2026-01-22 -40.99
2026-01-21 -41.07
2026-01-20 -41.07
2026-01-16 -40.94
2026-01-15 -40.91
2026-01-14 -40.86
2026-01-13 -41.18
2026-01-12 -41.07
2026-01-09 -40.36
2026-01-08 -40.36
2026-01-07 -40.36
2026-01-06 -40.42
2026-01-05 -40.36
2026-01-02 -40.28
2025-12-31 -40.28
2025-12-30 -40.26
2025-12-29 -40.26
2025-12-26 -40.28
2025-12-24 -40.28
2025-12-23 -29.15
2025-12-22 -29.23